4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-26-020709
Director sold 10,800 shares at $7.20 ($77,748)
- Director acquired 27,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WILSON TROY EDWARD Director | 2026-06-11 | Grant or award 10b5-1 | +27,000 | 70,550 | D | ||
| WILSON TROY EDWARD Director | 2026-06-12 | Sale 10b5-1 | −10,800 | $7.20 | $77,748 | 59,750 | D |
| Open-market sales · 10,800 sh · avg $7.20 · $77,748 | |||||||
Loading xslF345X06/rdgdoc.xml…